KR20000048765A - 붉은 효모 발효 생성물을 이용하는 방법 및 그 조성물 - Google Patents

붉은 효모 발효 생성물을 이용하는 방법 및 그 조성물 Download PDF

Info

Publication number
KR20000048765A
KR20000048765A KR1019990702751A KR19997002751A KR20000048765A KR 20000048765 A KR20000048765 A KR 20000048765A KR 1019990702751 A KR1019990702751 A KR 1019990702751A KR 19997002751 A KR19997002751 A KR 19997002751A KR 20000048765 A KR20000048765 A KR 20000048765A
Authority
KR
South Korea
Prior art keywords
red yeast
monascus
fermentation product
yeast fermentation
human
Prior art date
Application number
KR1019990702751A
Other languages
English (en)
Korean (ko)
Inventor
마오엘. 장
차이엑스. 퐁
마이클엔. 창
Original Assignee
팔마넥스 인코퍼레이티드
페킹 유니버시티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 팔마넥스 인코퍼레이티드, 페킹 유니버시티 filed Critical 팔마넥스 인코퍼레이티드
Publication of KR20000048765A publication Critical patent/KR20000048765A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
KR1019990702751A 1996-09-30 1997-09-29 붉은 효모 발효 생성물을 이용하는 방법 및 그 조성물 KR20000048765A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72054896A 1996-09-30 1996-09-30
US8/720,548 1996-09-30

Publications (1)

Publication Number Publication Date
KR20000048765A true KR20000048765A (ko) 2000-07-25

Family

ID=24894390

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990702751A KR20000048765A (ko) 1996-09-30 1997-09-29 붉은 효모 발효 생성물을 이용하는 방법 및 그 조성물

Country Status (9)

Country Link
EP (1) EP0932395A1 (fr)
JP (1) JP2001501621A (fr)
KR (1) KR20000048765A (fr)
AU (1) AU4658797A (fr)
BR (1) BR9712168A (fr)
CA (1) CA2267340A1 (fr)
HU (1) HUP9904650A2 (fr)
IL (1) IL129216A0 (fr)
WO (1) WO1998014177A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426880B1 (ko) * 2002-02-04 2004-04-13 학교법인 영광학원 모나스쿠스 피로수스를 이용한 적색 메주색소의 제조방법

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436406B1 (en) 2000-06-15 2002-08-20 A. Glenn Braswell Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
AU2004249060A1 (en) * 2003-06-24 2004-12-29 Otsuka Pharmaceutical Co., Ltd. Composition for lowering serum uric acid level
US20100119600A1 (en) * 2007-06-01 2010-05-13 Joar Opheim Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
TW201038205A (en) * 2009-04-29 2010-11-01 Sunway Biotech Co Ltd The compositions of Monascus fermented products with a function that reduces body fatness formation and the method for manufacturing the same
JP2010273569A (ja) * 2009-05-26 2010-12-09 Wasaburo Sato メタボリックシンドローム改善作用を有する飲料及びサプリメント
JP5912361B2 (ja) * 2011-09-16 2016-04-27 晨暉生物科技股▲分▼有限公司 血液脂質を引き下げ、hdlコレステロールを引き上げることができる混合物とその製造方法
CN104024270B (zh) 2011-12-26 2016-07-06 北京北大维信生物科技有限公司 一种甾醇类衍生物、其制备方法及用途
CN113171316B (zh) * 2021-04-23 2022-06-14 科丝美诗(中国)化妆品有限公司 一种修复、缓解皮肤刺激化妆品及制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JP3168298B2 (ja) * 1993-02-05 2001-05-21 有限会社フジ・バイオ研究所 紅麹を使用した酒精飲料の製造法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426880B1 (ko) * 2002-02-04 2004-04-13 학교법인 영광학원 모나스쿠스 피로수스를 이용한 적색 메주색소의 제조방법

Also Published As

Publication number Publication date
CA2267340A1 (fr) 1998-04-09
IL129216A0 (en) 2000-02-17
BR9712168A (pt) 2000-01-18
JP2001501621A (ja) 2001-02-06
HUP9904650A2 (hu) 2000-05-28
AU4658797A (en) 1998-04-24
WO1998014177A1 (fr) 1998-04-09
EP0932395A1 (fr) 1999-08-04

Similar Documents

Publication Publication Date Title
US6046022A (en) Methods and compositions employing red rice fermentation products
Erdoğrul et al. Review of the studies on the red yeast rice (Monascus purpureus)
CN102586119B (zh) 一种功能红曲菌株及其功能青稞红曲制备方法和应用
CN106798252B (zh) 一种具有调理肠胃降血脂溶血栓功效的纳豆产品
US20160213731A1 (en) Composition comprising fermented tea extracts for reducing lipid level
KR20000048765A (ko) 붉은 효모 발효 생성물을 이용하는 방법 및 그 조성물
KR20210098225A (ko) 감귤 발효 콤부차를 유효성분으로 포함하는 당뇨 또는 심혈관질환 치료용 조성물
CN107468757A (zh) 桑葚花色苷在缓解自噬介导的肝细胞脂质沉积中的应用
CN110074392A (zh) 一种解酒保肝养胃护肠组合物及其制备方法
KR100416650B1 (ko) 둥굴레 추출물과 그를 함유한 혈장 지질 및 혈당 강하용조성물
ERDOĞRUL et al. A review on the red yeast rice (Monascus purpureus)
MXPA99003004A (en) Methods and compositions employing red yeast fermentation products
KR20120021044A (ko) 홍국산약의 제조방법
CN108850923A (zh) 一种水果功能红曲的制备方法
KR100742340B1 (ko) 혈중 콜레스테롤 수치를 개선하는 홍국균 배양조성물의제조방법.
KR100468648B1 (ko) 저지혈증 효과를 갖는 영지버섯 유래의 세포외다당체와 세포내다당체 및 그 용도
CZ111899A3 (cs) Farmaceutický prostředek
KR101827701B1 (ko) 콜레스테롤 및 담즙산 배출능이 우수한 기능성 발효유 및 이의 제조방법
KR20230112802A (ko) 유산균을 이용한 알파-글루코사이드 활성 저해능을 가지는 혈당강하용 조성물, 건강기능식품 및 약학적 조성물
KR20060023762A (ko) 고지혈증 및 혈소판 응집에 대해 억제작용을 갖는대두발효 추출물과 이를 이용한 조성물
KR20130096588A (ko) 고상발효법을 이용한 산마늘 발효물의 제조방법 및 산마늘 발효물을 포함하는 당뇨 또는 당뇨합병증 예방 또는 치료용 조성물
CN109793216A (zh) 一种红曲沙棘籽仁粉的制备方法
CN111135229A (zh) 具有调整血糖、血脂、血压和尿酸功能的中药组合物及其制备方法
JP2002275088A (ja) 動脈硬化防止剤
KR20040009808A (ko) 콜레스테롤 저하 및 비만치료 특수버섯과 이의 가공품

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid